Nitric oxide-dependent pro-oxidant and pro-apoptotic effect of metallothioneins in HL-60 cells challenged with cupric nitrilotriacetate.
Intracellular safeguarding functions of metallothioneins (MTs) include sequestering transition and heavy metals, scavenging free radicals and protecting against electrophiles. We report that MT protection against Cu-induced cytotoxicity can be reversed and pro-oxidant and pro-apoptotic effects can be induced in HL-60 cells exposed to NO. We demonstrate that in ZnCl(2)-pretreated HL-60 cells loaded with copper nitrilotriacetate (Cu-NTA), exposure to an NO donor, S-nitroso-N-acetyl penicillamine, resulted in S-nitrosylation and oxidation of MT cysteines. This disruption of MT Cu-binding thiolate clusters caused loosening and release of redox-active Cu, enhanced redox-cycling activity of Cu and increased peroxidation of major classes of membrane phospholipids. We also found that Cu-induced oxidative stress in ZnCl(2)-pretreated/Cu-NTA-loaded HL-60 cells was accompanied by apoptosis documented by characteristic changes of nuclear morphology, internucleosomal DNA cleavage, externalization of phosphatidylserine, release of cytochrome c from mitochondria into cytosol and activation of caspase-3. We conclude that in Cu-challenged cells, NO can reverse the protective role of MTs and convert them into pro-oxidant, pro-apoptotic implements.
Liu
S
S
Department of Environmental and Occupational Health, University of Pittsburgh, 260 Kappa Drive, Pittsburgh, PA 15238, U.S.A.
Kawai
K
K
Tyurin
V A
VA
Tyurina
Y Y
YY
Borisenko
G G
GG
Fabisiak
J P
JP
Quinn
P J
PJ
Pitt
B R
BR
Kagan
V E
VE
D017304:Annexin A5 / Q000378:metabolism; D017209:Apoptosis / Q000187:drug effects; D002273:Carcinogens / Q000494:pharmacology*; D053148:Caspase 3; D020169:Caspases / Q000378:metabolism; D002712:Chlorides / Q000494:pharmacology; D002851:Chromatography, High Pressure Liquid; D003574:Cytochrome c Group / Q000378:metabolism; D053938:DNA Fragmentation; D004578:Electron Spin Resonance Spectroscopy; D004789:Enzyme Activation; D018922:HL-60 Cells; D006801:Humans; D015227:Lipid Peroxidation; D008668:Metallothionein / Q000494:pharmacology*; D009569:Nitric Oxide / Q000378:metabolism*; D020030:Nitric Oxide Donors / Q000378:metabolism; D009571:Nitrilotriacetic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology*; D009942:Organometallic Compounds / Q000494:pharmacology*; D016877:Oxidants / Q000378:metabolism*; D010084:Oxidation-Reduction; D010396:Penicillamine / Q000031:analogs & derivatives* / Q000378:metabolism; D010743:Phospholipids / Q000378:metabolism; D017967:Zinc Compounds / Q000494:pharmacology
D017304:Annexin A5; D002273:Carcinogens; D002712:Chlorides; D003574:Cytochrome c Group; D020030:Nitric Oxide Donors; D009942:Organometallic Compounds; D016877:Oxidants; D010743:Phospholipids; C110881:S-nitro-N-acetylpenicillamine; D017967:Zinc Compounds; D009569:Nitric Oxide; C016837:zinc chloride; D008668:Metallothionein; C060581:cupric nitrilotriacetate; C505407:CASP3 protein, human; D053148:Caspase 3; D020169:Caspases; D010396:Penicillamine; D009571:Nitrilotriacetic Acid